265 related articles for article (PubMed ID: 23744990)
1. Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions.
Segers FM; den Adel B; Bot I; van der Graaf LM; van der Veer EP; Gonzalez W; Raynal I; de Winther M; Wodzig WK; Poelmann RE; van Berkel TJ; van der Weerd L; Biessen EA
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1812-9. PubMed ID: 23744990
[TBL] [Abstract][Full Text] [Related]
2. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives.
Burtea C; Ballet S; Laurent S; Rousseaux O; Dencausse A; Gonzalez W; Port M; Corot C; Vander Elst L; Muller RN
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):e36-48. PubMed ID: 22516067
[TBL] [Abstract][Full Text] [Related]
3. Design and validation of a specific scavenger receptor class AI binding peptide for targeting the inflammatory atherosclerotic plaque.
Segers FM; Yu H; Molenaar TJ; Prince P; Tanaka T; van Berkel TJ; Biessen EA
Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):971-8. PubMed ID: 22282357
[TBL] [Abstract][Full Text] [Related]
4. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10.
Raynal I; Prigent P; Peyramaure S; Najid A; Rebuzzi C; Corot C
Invest Radiol; 2004 Jan; 39(1):56-63. PubMed ID: 14701989
[TBL] [Abstract][Full Text] [Related]
5. In vivo MRI detection of carotid atherosclerotic lesions and kidney inflammation in ApoE-deficient mice by using LOX-1 targeted iron nanoparticles.
Wen S; Liu DF; Cui Y; Harris SS; Chen YC; Li KC; Ju SH; Teng GJ
Nanomedicine; 2014 Apr; 10(3):639-49. PubMed ID: 24103305
[TBL] [Abstract][Full Text] [Related]
6. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E
Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378
[TBL] [Abstract][Full Text] [Related]
8. Scavenger receptor-AI-targeted ultrasmall gold nanoclusters facilitate in vivo MR and ex vivo fluorescence dual-modality visualization of vulnerable atherosclerotic plaques.
Wang J; Wu M; Chang J; Li L; Guo Q; Hao J; Peng Q; Zhang B; Zhang X; Li X
Nanomedicine; 2019 Jul; 19():81-94. PubMed ID: 31028886
[TBL] [Abstract][Full Text] [Related]
9. T1-weighted MRI of targeting atherosclerotic plaque based on CD40 expression on engulfed USPIO's cell surface.
Huang C; Huang W; Meng Y; Zhou C; Wang X; Zhang C; Tian Y; Wei W; Li Y; Zhou Q; Chen W; Tang Y
Biomed Mater; 2024 Jan; 19(2):. PubMed ID: 38215489
[TBL] [Abstract][Full Text] [Related]
10. Direct recognition of superparamagnetic nanocrystals by macrophage scavenger receptor SR-AI.
Chao Y; Karmali PP; Mukthavaram R; Kesari S; Kouznetsova VL; Tsigelny IF; Simberg D
ACS Nano; 2013 May; 7(5):4289-98. PubMed ID: 23614696
[TBL] [Abstract][Full Text] [Related]
11. MRI study of atherosclerotic plaque progression using ultrasmall superparamagnetic iron oxide in Watanabe heritable hyperlipidemic rabbits.
Kaneko C; Nitta N; Tsuchiya K; Watanabe S; Nitta-Seko A; Ohta S; Otani H; Sonoda A; Murata K; Shiomi M
Br J Radiol; 2015 Sep; 88(1053):20150167. PubMed ID: 26083261
[TBL] [Abstract][Full Text] [Related]
12. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
13. Multiscale investigation of USPIO nanoparticles in atherosclerotic plaques and their catabolism and storage in vivo.
Maraloiu VA; Appaix F; Broisat A; Le Guellec D; Teodorescu VS; Ghezzi C; van der Sanden B; Blanchin MG
Nanomedicine; 2016 Jan; 12(1):191-200. PubMed ID: 26370708
[TBL] [Abstract][Full Text] [Related]
14. Polymer-Lipid Hybrid Theranostic Nanoparticles Co-Delivering Ultrasmall Superparamagnetic Iron Oxide and Paclitaxel for Targeted Magnetic Resonance Imaging and Therapy in Atherosclerotic Plaque.
Dong Y; Chen H; Chen C; Zhang X; Tian X; Zhang Y; Shi Z; Liu Q
J Biomed Nanotechnol; 2016 Jun; 12(6):1245-57. PubMed ID: 27319218
[TBL] [Abstract][Full Text] [Related]
15. Dual-modality imaging of atherosclerotic plaques using ultrasmall superparamagnetic iron oxide labeled with rhodamine.
Li Y; Pan Y; Wu X; Li Y; Wang H; Zhu H; Jiang L
Nanomedicine (Lond); 2019 Aug; 14(15):1935-1944. PubMed ID: 31355711
[No Abstract] [Full Text] [Related]
16. Feraheme (Ferumoxytol) Is Recognized by Proinflammatory and Anti-inflammatory Macrophages via Scavenger Receptor Type AI/II.
Wang G; Serkova NJ; Groman EV; Scheinman RI; Simberg D
Mol Pharm; 2019 Oct; 16(10):4274-4281. PubMed ID: 31556296
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessment.
Olzinski AR; Turner GH; Bernard RE; Karr H; Cornejo CA; Aravindhan K; Hoang B; Ringenberg MA; Qin P; Goodman KB; Willette RN; Macphee CH; Jucker BM; Sehon CA; Gough PJ
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):253-9. PubMed ID: 19965779
[TBL] [Abstract][Full Text] [Related]
18. Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI.
Tarin C; Carril M; Martin-Ventura JL; Markuerkiaga I; Padro D; Llamas-Granda P; Moreno JA; García I; Genicio N; Plaza-Garcia S; Blanco-Colio LM; Penades S; Egido J
Sci Rep; 2015 Nov; 5():17135. PubMed ID: 26616677
[TBL] [Abstract][Full Text] [Related]
19. Receptor-targeted iron oxide nanoparticles for molecular MR imaging of inflamed atherosclerotic plaques.
Tu C; Ng TS; Sohi HK; Palko HA; House A; Jacobs RE; Louie AY
Biomaterials; 2011 Oct; 32(29):7209-16. PubMed ID: 21742374
[TBL] [Abstract][Full Text] [Related]
20. In vivo MRI detection of atherosclerosis in ApoE-deficient mice by using tenascin-C-targeted USPIO.
Li Y; Liu J; Huang JW; Song JC; Ma ZL; Shi HB
Acta Radiol; 2018 Dec; 59(12):1431-1437. PubMed ID: 29566551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
